26Aug
Financial Daily Dose 8.26.2019 | Top Story: Amgen to Pay More Than $13 Billion for Otezla
Amgen will pay $13.4 billion in cash to buy psoriasis treatment Otezla, a deal that will “pave the way for Bristol-Myers Squibb to complete its acquisition of Celgene” by addressing “regulatory concerns over their union”....
By:
Robins Kaplan LLP
Related
On August 23, 2019, the National Labor Relations Board ("NLRB") determined that property owners may ...
Read More >
Key Points - The US Court of Appeals for the First Circuit reversed a lower court decision which he...
Read More >
In an important step for California, Governor Gavin Newsom signed SB 188 into law on July 3, 2019. S...
Read More >
While all of us are still firmly entrenched within the early stages of the global response to the CO...
Read More >
BakerHostetler invites you to join us for an upcoming webinar, Federal Trade Commission - Antitrust ...
Read More >
On December 17, 2019, the US House of Representatives passed a year-end fiscal year 2020 spending bi...
Read More >